Log in
Enquire now
KPI Therapeutics

KPI Therapeutics

KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.

OverviewStructured DataIssuesContributors

Contents

kpitherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Autoimmune disease
Autoimmune disease
Drug development
Drug development
Therapeutics
Therapeutics
Healthcare
Healthcare
Location
‌
Seattle, Washington, United States
CEO
‌
Charles Magness
Founder
‌
Charles Magness
AngelList URL
angel.co/kpi-therapeutics
Investors
AngelMD
AngelMD
Keiretsu Capital
Keiretsu Capital
TSVC
TSVC
Keiretsu Forum
Keiretsu Forum
Founded Date
2013
Total Funding Amount (USD)
27,000
Latest Funding Type
Series A
Series A
Wellfound ID
kpi-therapeutics

Other attributes

Company Operating Status
Active

KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies. Its platform targets autoimmune diseases of the skin that have millions of sufferers in the US and are a multi-billion-dollar market. Its lead drug, dalazatide, has completed Phase 1 trials and demonstrated clinical activity in patients.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like KPI Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.